PBS NewsHour

Waiving the vaccine patent may depend on incentives

President Joe Biden has given the initial nod for the U.S. to waive patent rights on COVID vaccines to boost international production. But there are real questions over how effective these moves would be, what other countries feel about it, and when this would translate into action. William Brangham discusses the matter with Rachel Silverman, a policy fellow at the Center for Global Development.

Waiving the vaccine patent may depend on incentives

6m 44s

WETA Passport

Stream tens of thousands of hours of your PBS and local favorites with WETA Passport whenever and wherever you want. Catch up on a single episode or binge-watch full seasons before they air on TV.